TFM
UNCY icon

TFC Financial Management’s Unicycive Therapeutics UNCY Stock Holding History

TFC Financial Management’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41K Hold
300
– – ﹤0.01% 613
2026
Q1 		$1.97K Hold
300
– – ﹤0.01% 537
2025
Q4 		$1.73K Hold
300
– – ﹤0.01% 541
2025
Q3 		$1.31K Buy
+300
New +$1.31K ﹤0.01% 601

Other funds holding UNCY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

TFC Financial Management's UNCY Position: Q2 2026 in Review

TFC Financial Management held its Unicycive Therapeutics (UNCY) position steady in Q2 2026 at 300 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #613.

TFC Financial Management first reported a position in UNCY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.97K in Q1 2026. 80 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • TFC Financial Management held 300 shares of Unicycive Therapeutics worth $1.41K as of Q2 2026.
  • TFC Financial Management left its Unicycive Therapeutics share count unchanged in Q2 2026.
  • Unicycive Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #613 holding.
  • TFC Financial Management first reported a position in Unicycive Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • TFC Financial Management's Unicycive Therapeutics position peaked at $1.97K in Q1 2026.
  • 80 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.